Clinical Trial: Exploratory study of the targeting efficacy of fibroblast activator protein FAP in primary and metastatic lesions of solid tumors (China)

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploratory study of the targeting efficacy of fibroblast activator protein FAP in primary and metastatic lesions of solid tumors'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134687

Registration Time: 2026/10/19

Type: Diagnostic test

Primary Sponsor: The First Affiliated Hospital of Jinan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=263544

Published by HT Digital Content Services with permission from Health Daily Digest....